Study to investigate the effects of AZD6140 in patients with renal impairment and in healthy volunteers
Study identifier:D5130C00015
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Study to investigate the effects of AZD6140 in patients with renal impairment and in healthy volunteers
Medical condition
Renal Impairment
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD6140
Sex
All
Actual Enrollment
24
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Feb 2007
Primary Completion Date: 01 Sept 2008
Study Completion Date: 01 Sept 2008
Study design
Allocation: Non-randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: AZD6140 | Drug: AZD6140 single oral dose |
Contacts
Investigators
Principal Investigator
Kathleen Butler
AstraZeneca Pharmaceuticals
